Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3, Multicenter, Multinational, Open-Label Study to Evaluate the Safety and Efficacy of Alfimeprase in Subjects With Occluded Central Venous Access Devices (SONOMA-3)

NCT00322270 is registered in ClinicalTrials.gov with ARCA Biopharma, Inc. as lead sponsor.

NCT NCT00322270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00322270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3, Multicenter, Multinational, Open-Label Study to Evaluate the Safety and Efficacy of Alfimeprase in Subjects With Occluded Central Venous Access Devices (SONOMA-3)
Lead sponsor
ARCA Biopharma, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2006
Completion date
Not reported
Enrollment
Not reported
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

catheter occlusion, thrombosis, venous thrombosis